Dr Marvel Adapalene 0.1% Gel Acne Treatment
- Product NDC
- 87536-009
- Requested package NDC
- 87536-009-01
- 11-digit product format
- 875360009
- Labeler code
- 87536
- Product ID
- 87536-009_5f8d4794-fb41-1a61-e063-6394a90a70b3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Adapalene Gel
- Dosage form
- GEL
- Route
- CUTANEOUS
- Labeler
- Huain Best Trade Co., Ltd.
- Application
- M006
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2026-11-06
- Substance
- ADAPALENE
- Active strength
- .1 mg/100mg
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dr Marvel Adapalene 0.1% Gel Acne Treatment
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ADAPALENE | .1 mg/100mg |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1L4806J2QF | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5f8d478b-09cb-1c8f-e063-6394a90a19aa | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REPLENIX ACNE Solution BENZOYL PEROXIDE WASH | BENZOYL PEROXIDE | Topiderm, Inc. | 235e9dd5-13f2-4078-9807-1d87fd9e6cba | 2019-12-17 | Warnings | M006 |
| Replenix Acne | BENZOYL PEROXIDE | Topiderm, Inc | 03d4c298-8f44-41f7-b086-96ae836152bb | 2019-10-31 | Warnings | M006 |
| Replenix Acne | BENZOYL PEROXIDE | Topiderm, Inc. | c12f9005-a549-4447-9beb-df7126f77df1 | 2019-10-31 | Warnings | M006 |
| Gly-Sal 10-2 Pads | SALICYLIC ACID | Topiderm, Inc. | b39e845d-4c40-4f9e-9cb5-a8386f326652 | 2019-10-23 | Warnings | M006 |
| Gly-Sal 5-2 Pads | SALICYLIC ACID | Topiderm, Inc. | e73bd26c-cdc2-47ab-94e8-3bc49a9b19e8 | 2019-10-22 | Warnings | M006 |
| SKIN MEDICA Purifying Foaming Wash | SALICYLIC ACID | Allergan, Inc. | 064d9e2b-077f-4229-b653-666fc5479ae2 | 2013-03-01 | Warnings | M006 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 87536-009-01 | 87536000901 | 50 mg in 1 BOTTLE (87536-009-01) | 50 mg | 2026-11-06 | No | No | Current |